Losartan and dapagliflozin combination therapy in reducing uric acid level compared to monotherapy in patients with heart failure

Losartan and dapagliflozin combination therapy in reducing uric acid level compared to monotherapy in patients with heart failure

Background Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors, and Angiotensin II Receptor Antagonists (ARBs) also have the effect of reducing serum uric acid but few studies worldwide assessed. Objective Evaluate the effectiveness of serum uric acid lowering treatment of SGLT2 inhibitors, and AR...

Full description

Saved in:
Bibliographic Details
Main Authors: Tuong Le Trong Huynh, Phong Thanh Pham, Hien Dieu Tran, Nhan Dinh Tran, Duong Van Tran, Bao Lam Thai Tran, Khoa Dang Dang Tran, Toan Hoang Ngo, Son Kim Tran
Format: Article
Language:English
Published: PeerJ Inc. 2024-11-01
Series:PeerJ
Subjects:
Heart failure
Losartan
Dapagliflozin
Uric acid reduction
Combination therapy
Online Access:https://peerj.com/articles/18595.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://peerj.com/articles/18595.pdf

Similar Items